Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-28T00:34:55.300Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of Education and an Antifungal Stewardship Program for Candidiasis at a Thai Tertiary Care Center

Published online by Cambridge University Press:  02 January 2015

Anucha Apisarnthanarak ,
Apiwat Yatrasert ,
Linda M. Mundy  and
Thammasat University Antimicrobial Stewardship Team
Anucha Apisarnthanarak*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Thammasat University Hospital, Pratumthani, Thailand
Apiwat Yatrasert
Affiliation:
Division of Infectious Diseases, Department of Medicine, Thammasat University Hospital, Pratumthani, Thailand
Linda M. Mundy
Affiliation:
L. M. Mundy, LLC, Bryn Mawr, Pennsylvania
*
Division of Infectious Diseases, Thammasat University Hospital, Klong Luang 662-997-21, Pratumthani, 12120, Thailand ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

Background.

We evaluated the impact of education and an antifungal stewardship program for candidiasis on prescribing practices, antifungal consumption, Candida species infections, and estimated costs at a Thai tertiary care hospital.

Methods.

A hospital-wide, quasi-experimental study was conducted for 1.5 years before the intervention and 1.5 years after the implementation of an antifungal stewardship program. Inpatient antifungal prescriptions were prospectively observed, and patients' demographic, clinical, and administrative-cost data were collected. Interventions included education, introduction of an antifungal hepatic and/or renal dose adjustment tool, antifungal prescription forms, and prescription-control strategies.

Results.

After the intervention, there was a 59% reduction in antifungal prescriptions (from 194 to 80 prescriptions per 1,000 hospitalizations; P < .001). Inappropriate antifungal use decreased (from 71% to 24%; P < .001), a sustained reduction in antifungal use was observed (r = 0.83; P < .001), and fluconazole use decreased (from 242 to 117 defined daily doses per 1,000 patient-days; P < .001). Reductions in the incidence of infection with Candida glabrata (r = 0.69; P < .001) and Candida krusei (r = 0.71; P < .001) were observed, whereas the incidence of infection with Candida albicans (r = —0.81; P < .001) increased. Total cost savings were US$31,615 during the 18-month postintervention period.

Conclusions.

Implementation of an antifungal stewardship program was associated with appropriate antifungal drug use, improved resource utilization, and cost savings.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 7 , July 2010 , pp. 722 - 727
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Loeffler, J, Stevens, DA. Antifungal drug resistance. Clin Infect Dis 2003;36(suppl 1):S31–S41.Google Scholar
2.Masiá Canuto, M, Gutiérrez Rodero, F. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002;2:550–563.Google Scholar
3.Bicanic, T, Harrison, T, Niepieklo, A, Dyakopu, N, Meintjes, G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006;43:1069–1073.CrossRefGoogle ScholarPubMed
4.González, GM, Elizondo, M, Ayala, J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 2008;46:2902–2905.CrossRefGoogle ScholarPubMed
5.Pfaller, MA, Diekema, DJ, Gibbs, DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007;45:1735–1745.CrossRefGoogle ScholarPubMed
6.Kanamaru, A, Tatsumi, Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis 2004;39(suppl 1):S7–S10.Google Scholar
7.Apisarnthanarak, A, Danchaivijitr, S, Khawcharoenporn, T, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006;42:768–775.Google Scholar
8.Dellit, TH, Owens, RC, McGowan JE, Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
9.Paterson, DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006;42(suppl 2):S90–S95.Google Scholar
10.Pagani, L, Gyssens, IC, Huttner, B, Nathwani, D, Harbarth, S. Navigating the Web in search of resources on antimicrobial stewardship in healthcare institutions. Clin Infect Dis 2009;48:626–632.Google Scholar
11.Sutepvarnon, A, Apisarnthanarak, A, Camins, B, Mondy, K, Fraser, VJ. Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study. Infect Control Hosp Epidemiol 2008;29: 370–373.CrossRefGoogle Scholar
12.Maxwell, M, Heaney, D, Howie, JG, Noble, S. General practice fund holding: observations on prescribing patterns and costs during the defined daily dose method. BMJ 1993;307:1190–1194.Google Scholar
13.Pappas, PG, Kauffman, CA, Andes, D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503–535.CrossRefGoogle ScholarPubMed
14.Kunin, CM, Tupasi, T, Craig, WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med 1973;79: 555–560.Google Scholar
15.Warren, JW, Abrutyn, E, Hebel, JR. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis. Clin Infect Dis 1999;29:745–748.CrossRefGoogle ScholarPubMed
16.Lundstrom, T, Sobel, J. Nosocomial candiduria: a review. Clin Infect Dis 2001;32:1602–1607.Google ScholarPubMed
17.Gutierrez, F, Patrick, GW, Cohen, J. Antimicrobial practice: an audit of the use of antifungal agents. J Antimicrob Chemother 1996;37:175–185.Google Scholar